📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Cardiac, renal, and metabolic effects of sodium-glucose co-transporter 2 inhibitors: a position paper from the European Society of Cardiology ad-hoc task force on sodium-glucose co-transporter 2 inhibitors. (2021)

First Author: Herrington WG

Attributed to: Vascular disease meta analyses funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/ejhf.2286

PubMed Identifier: 34184823

Publication URI: http://europepmc.org/abstract/MED/34184823

Type: Journal Article/Review

Volume: 23

Parent Publication: European journal of heart failure

Issue: 8

ISSN: 1388-9842